PharmaCyte Biotech, Inc. (PMCB)

Recent Material Events for PharmaCyte Biotech, Inc.
Date Description
Dec 17, 2012 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate).
Dec 17, 2012 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate).
Sep 14, 2012 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate).
Aug 14, 2012 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “ l arge accelerated filer, ” “ accelerated filer ”
Jul 30, 2012 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate).
Jun 28, 2012 In connection with the Asset Purchase Agreement mentioned in Item 2.01, the Company issued 100,000,000 shares of unregistered, restricted common stock to the owners of Austrianova Singapore Pte. Ltd. The shares were issued under Rule 144 of the Secur
Feb 15, 2012 (b) On February 10, 2012, the Company engaged ROBISON, HILL & COMPANY as the Company's independent accountant to audit the Company’s financial statements and to perform reviews of interim financial statements. During the fiscal years ended A
Feb 15, 2012 (b) On February 10, 2012, the Company engaged ROBISON, HILL & COMPANY as the Company's independent accountant to audit the Company’s financial statements and to perform reviews of interim financial statements. During the fiscal years ended A
Jan 24, 2012 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Sep 14, 2011 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)